Alosenta begins Immunogenicity/Tox Studies, including Toxicity Study in NCG immunodeficient mice, in collaboration with TransCure BioServices. Exciting progress ahead!
Alosenta begins Immunogenicity/Tox Studies, including Toxicity Study in NCG immunodeficient mice, in collaboration with TransCure BioServices. Exciting progress ahead!